ArticlePharmaceuticals (Basel, Switzerland)2025

Evaluating the Use of Inhaled Budesonide and Ipratropium Bromide Combination in Patients at High Risk of Acute Respiratory Distress Syndrome Development: A Randomized Controlled Trial.

Hebatallah Ahmed Mohamed Moustafa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.